home / stock / tcbp / tcbp news

TCBP News and Press, TC BioPharm (Holdings) plc From 03/22/23

Stock Information
Company Name: TC BioPharm (Holdings) plc
Stock Symbol: TCBP
Market: NASDAQ
Website: tcbiopharm.com
Menu
TCBP TCBP Quote TCBP Short TCBP News TCBP Articles TCBP Message Board
Get TCBP Alerts

News, Short Squeeze, Breakout and More Instantly...
TCBP - TC Biopharm to cut 30% of staff in restructuring drive

2023-03-22 09:25:07 ET The U.K.-based nanocap biotech TC Biopharm ( NASDAQ: TCBP ) announced a major restructuring initiative on Wednesday indicating plans to reduce up to 30% of its staff count, mostly within the first half of 2023. The company expects to realize more tha...
TCBP - TC Biopharm Announces Corporate Restructuring, Reduction in Overhead

TC Biopharm Announces Corporate Restructuring, Reduction in Overhead PR Newswire Extends cash runway Realigned to reflect corporate strategic vision EDINBURGH, Scotland , March 22, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPh...

TCBP - TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2)

TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2) PR Newswire EDINBURGH, Scotland , March 16, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a cli...

TCBP - THMO, KTRA and RCON among mid-day movers

2023-03-15 12:48:54 ET Gainers: Moolec ( MLEC ) +86% . Thermo Genesis ( THMO ) +82% . Loyalty Ventures ( LYLT ) +51% . Elevation Oncology ( ELEV ) +41% . Jounce ( JNCE ) +40% . Etao International ( ETAO ) +23% . M...
TCBP - TC BioPharm Shifts Focus to FDA Clinical Trials

TC BioPharm Shifts Focus to FDA Clinical Trials PR Newswire Company to explore US IND pathway for additional combination trials EDINBURGH, Scotland , March 7, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TC...

TCBP - TC BioPharm names Dr. Michael Leek as the CEO

Clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, TC BioPharm ( NASDAQ: TCBP ) appoints Dr. Michael Leek to the position of CTO. Dr. Leek resumes operational duties as CTO after stepping down as executi...

TCBP - TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer

TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer PR Newswire EDINBURGH, Scotland , Feb. 23, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platfo...
TCBP - TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies

TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies PR Newswire EDINBURGH, Scotland , Feb. 21, 2023 /PRNewswire/ -- TC BioPharm(Holdings) PLC ("TC BioPharm" or the "Company")...

TCBP - TC BioPharm Announces New Chair of the Board, Arlene Morris

TC BioPharm Announces New Chair of the Board, Arlene Morris PR Newswire EDINBURGH, Scotland , Feb. 14, 2023 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company deve...

TCBP - TC BioPharm to Reschedule Shareholder Update Call and Webcast

TC BioPharm to Reschedule Shareholder Update Call and Webcast PR Newswire Conference Call to be held on Tuesday, February 21 st , 2023 at Noon ET EDINBURGH, Scotland , Feb. 13, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm"...
Previous 10 Next 10